Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
INSPRA 25 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. 25 mg tablet: yellow tablet with stylized “Pfizer” on one side of tablet, “NSR” over "25"on the other side of tablet. |
Each tablet contains 25 mg of eplerenone.
Excipients with known effect: Each 25 mg tablet contains 35.7 mg of lactose monohydrate (see section 4.4).
For the full list of excipients see section 6.1.
| Active Ingredient |
|---|
|
Eplerenone has relative selectivity in binding to recombinant human mineralocorticoid receptors compared to its binding to recombinant human glucocorticoid, progesterone and androgen receptors. Eplerenone prevents the binding of aldosterone, a key hormone in the renin-angiotensin-aldosterone-system (RAAS), which is involved in the regulation of blood pressure and the pathophysiology of CV disease. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Tablet coating: Opadry yellow: Hypromellose (E464) |
Opaque PVC/Al blisters containing 10, 20, 28, 30, 50, 90, 100 or 200 tablets.
Opaque PVC/Al perforated unit dose blisters containing 10 × 1, 20 × 1, 30 × 1, 50 × 1, 90 × 1, 100 × 1 or 200 × 1 (10 packs of 20 × 1) tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0615
21/09/2004
| Drug | Countries | |
|---|---|---|
| INSPRA | Austria, Australia, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.